is tirzepatide a compound drug Republican Administration Maintains Exclusivity Stance in GLP-1 (Tirzepatide) Compounding Dispute Compounded Tirzepatide Online | Transparent
Description
As an example, the LEADER trial with liraglutide included 9,340 subjects and 1,302 MACE events whereas SUSTAIN-6 included 3,297 subjects with only 254 MACE events
The test examines variants in GLP1R, GIPR, FTO, and MC4R genes, which relate to peptide signaling pathways involved in appetite, satiety, and GI motility
These predispositions do not determine exact medication response, but they may help contextualize why some PCOS patients respond robustly to GLP-1 monotherapy while others require dual-receptor activation for meaningful improvement
See the GOLO Release product page, the company's studies page, and registered trial records such as the entry on ClinicalTrials.gov for more context
Retrieved August 2, 2022
Right now, it is not clear if people can get this side effect or not
